Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 6.61% is 69% below its 5-year average of 21.65%, around the middle of its 5-year range (-18.92%–34.02%).
10.91% below its 12-month average of 7.42%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 16.45%.
NET PROFIT MARGIN
6.61%
NET PROFIT MARGIN AVG TTM
7.42%
NET PROFIT MARGIN AVG 3Y
18.66%
NET PROFIT MARGIN AVG 5Y
21.65%
NET PROFIT MARGIN AVG 10Y
24.20%
NET PROFIT MARGIN AVG 15Y
17.70%
NET PROFIT MARGIN AVG 20Y
9.80%
CURRENT VS TTM AVG
-10.91%
CURRENT VS 3Y AVG
-64.57%
CURRENT VS 5Y AVG
-69.47%
CURRENT VS 10Y AVG
-72.68%
CURRENT VS 15Y AVG
-62.65%
CURRENT VS 20Y AVG
-32.57%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 373 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Corcept Therapeutics Incorporated
Market Cap
$13.19B
Net Profit Margin
6.61%
TTM Avg
7.42%
3Y Avg
18.66%
5Y Avg
21.65%
Market Cap
$12.95B
Net Profit Margin
-97.64%
TTM Avg
-193.35%
3Y Avg
-1980.08%
5Y Avg
-2361.16%
Market Cap
$12.89B
Net Profit Margin
3.99%
TTM Avg
6.17%
3Y Avg
6.60%
5Y Avg
6.82%
Market Cap
$12.52B
Net Profit Margin
-9.27%
TTM Avg
-7.30%
3Y Avg
-3.29%
5Y Avg
1.14%
Market Cap
$14.16B
Net Profit Margin
71.08%
TTM Avg
-67.82%
3Y Avg
-363.95%
5Y Avg
-2068.81%
Market Cap
$12.17B
Net Profit Margin
2.05%
TTM Avg
0.66%
3Y Avg
-0.28%
5Y Avg
0.00%
Market Cap
$12.00B
Net Profit Margin
10.01%
TTM Avg
9.01%
3Y Avg
7.89%
5Y Avg
8.30%
Market Cap
$14.64B
Net Profit Margin
-17.77%
TTM Avg
-60.53%
3Y Avg
-62.93%
5Y Avg
-77.31%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Corcept Therapeutics Incorporated (CORT) | $13.19B | 6.61% | 7.42% | 18.66% | 21.65% |
| BridgeBio Pharma, Inc. (BBIO)vs › | $12.95B | -97.64% | -193.35% | -1980.08% | -2361.16% |
| ICON Public Limited Company (ICLR)vs › | $12.89B | 3.99% | 6.17% | 6.60% | 6.82% |
| Baxter International Inc. (BAX)vs › | $12.52B | -9.27% | -7.30% | -3.29% | 1.14% |
| Penumbra, Inc. (PEN)vs › | $12.49B | 10.67% | 6.92% | 5.54% | 3.35% |
| Ascendis Pharma A/S (ASND)vs › | $14.16B | 71.08% | -67.82% | -363.95% | -2068.81% |
| BrightSpring Health Services, Inc. Common Stock (BTSG)vs › | $12.17B | 2.05% | 0.66% | -0.28% | 0.00% |
| Encompass Health Corporation (EHC)vs › | $12.00B | 10.01% | 9.01% | 7.89% | 8.30% |
| Tempus AI, Inc. (TEM)vs › | $14.64B | -17.77% | -60.53% | -62.93% | -77.31% |
| Exelixis, Inc. (EXEL)vs › | $14.79B | 35.33% | 28.88% | 23.04% | 19.31% |
Operating Margin
0.8%
Net Profit Margin
6.6%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 16.45% |
| 2026-03-31 | -18.92% |
| 2025-12-31 | 12.02% |
| 2025-09-30 | 9.47% |
| 2025-06-30 | 18.08% |
| 2025-03-31 | 13.07% |
| 2024-12-31 | 16.71% |
| 2024-09-30 | 25.58% |
| 2024-06-30 | 21.67% |
| 2024-03-31 | 18.91% |
| 2023-12-31 | 23.16% |
| 2023-09-30 | 25.39% |
| 2023-06-30 | 23.39% |
| 2023-03-31 | 15.03% |
| 2022-12-31 | 16.11% |
| 2022-09-30 | 34.02% |
| 2022-06-30 | 26.51% |
| 2022-03-31 | 24.33% |
| 2021-12-31 | 32.44% |
| 2021-09-30 | 31.70% |
| 2021-06-30 | 28.96% |
| 2021-03-31 | 29.54% |
| 2020-12-31 | 30.32% |
| 2020-09-30 | 25.05% |
| 2020-06-30 | 31.98% |
| 2020-03-31 | 32.24% |
| 2019-12-31 | 33.43% |
| 2019-09-30 | 32.32% |
| 2019-06-30 | 27.94% |
| 2019-03-31 | 28.19% |
| 2018-12-31 | 32.93% |
| 2018-09-30 | 27.54% |
| 2018-06-30 | 29.20% |
| 2018-03-31 | 30.28% |
| 2017-12-31 | 184.55% |
| 2017-09-30 | 32.17% |
| 2017-06-30 | 35.57% |
| 2017-03-31 | 15.90% |
| 2016-12-31 | 19.31% |
| 2016-09-30 | 11.90% |
| 2016-06-30 | 4.95% |
| 2016-03-31 | -0.12% |
| 2015-12-31 | 6.41% |
| 2015-09-30 | -4.53% |
| 2015-06-30 | -16.19% |
| 2015-03-31 | -47.81% |
| 2014-12-31 | -43.21% |
| 2014-09-30 | -82.48% |
| 2014-06-30 | -129.07% |
| 2014-03-31 | -316.23% |
| 2013-12-31 | -270.33% |
| 2013-09-30 | -414.05% |
| 2013-06-30 | -629.14% |
| 2013-03-31 | -703.79% |
| 2012-12-31 | -807.84% |
| 2012-09-30 | -786.07% |
| 2012-06-30 | -868.23% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 517000.00% |
| 2009-09-30 | -455.41% |
| 2009-06-30 | -81300.00% |
| 2009-03-31 | -22708.33% |
| 2008-12-31 | -4315.38% |
| 2008-09-30 | -8431.82% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | -378.88% |
| 2007-03-31 | -2347.22% |
| 2006-12-31 | -5310.96% |
| 2006-09-30 | 0.00% |
| 2006-06-30 | -7864.00% |
| 2006-03-31 | -5561.98% |
| 2005-12-31 | 0.00% |
| 2005-09-30 | 0.00% |
| 2005-06-30 | 0.00% |
| 2005-03-31 | 0.00% |
| 2004-12-31 | 0.00% |
| 2004-09-30 | 0.00% |
| 2004-06-30 | 0.00% |
| 2004-03-31 | 0.00% |
| 2003-12-31 | 0.00% |
| 2003-09-30 | 0.00% |
| 2003-06-30 | 0.00% |
| 2003-03-31 | 0.00% |
